GridAI Technologies (GRDX) Preferred Dividend Payments (2020 - 2025)
GridAI Technologies' (GRDX) quarterly Preferred Dividend Payments came in at $83068.0 in Q4 2025, down 7.9% YoY from $90189.0 in Q4 2024, and down 8.46% on a QoQ basis from $90745.0 in Q3 2025.
GridAI Technologies (GRDX) Preferred Dividend Payments (2020 - 2025) Analysis & Trends
GridAI Technologies (GRDX) has 6 years of Preferred Dividend Payments data on file, last reported at $83068.0 in Q4 2025.
- Quarterly Preferred Dividend Payments fell 7.9% year-over-year to $83068.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $337240.0 (up 20.86% YoY) and the FY2025 annual result came in at $337240.0, up 39.95% from the prior year.
- Preferred Dividend Payments declined to $83068.0 in Q4 2025, from $90745.0 in the prior quarter.
- In the past five years, Preferred Dividend Payments ranged from a high of $204382.0 in Q1 2021 to a low of $26661.0 in Q2 2021.
- A 5-year average of $87661.1 and a median of $84632.0 in 2024 frame the typical range for Preferred Dividend Payments.
- Annual changes were most pronounced in 2021 — Preferred Dividend Payments tumbled 87.17% — and 2022, when it jumped 264.3%.
- Tracing GRDX's Preferred Dividend Payments over 5 years: stood at $116229.0 in 2021, then fell by 16.44% to $97125.0 in 2022, then fell by 20.64% to $77081.0 in 2023, then grew by 17.01% to $90189.0 in 2024, then decreased by 7.9% to $83068.0 in 2025.
- The last three Preferred Dividend Payments figures came in at $83068.0 (Q4 2025), $90745.0 (Q3 2025), and $82165.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | GridAI Technologies | 5.82 Mn | 5.82 Mn | - | 83,068.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 83,068.00 |
| Sep 30, 2025 | 90,745.00 |
| Jun 30, 2025 | 82,165.00 |
| Mar 31, 2025 | 81,262.00 |
| Dec 31, 2024 | 90,189.00 |
| Sep 30, 2024 | 84,632.00 |
| Jun 30, 2024 | 38,058.00 |
| Mar 31, 2024 | 66,144.00 |
| Dec 31, 2023 | 77,081.00 |
| Sep 30, 2023 | 49,292.00 |
| Jun 30, 2023 | 94,324.00 |
| Jun 30, 2022 | 97,125.00 |
| Mar 31, 2022 | 90,792.00 |
| Dec 31, 2021 | 116,229.00 |
| Sep 30, 2021 | 118,089.00 |
| Jun 30, 2021 | 26,661.00 |
| Mar 31, 2021 | 204,382.00 |
| Dec 31, 2020 | 905,660.00 |